Global Anti-Obesity Drug Market- Regional Analysis
Among regions, North America is estimated to hold a dominant position in the global anti-obesity drug market over the forecast period due to the increasing burden of obesity and related chronic diseases and the increase in demand for anti-obesity drugs in the region. North America holds 42.1% of the market share. For instance, obesity in the U.S. is common and is a major health issue associated with numerous diseases, such as cancer, diabetes, and cardiovascular disease. Trust for America's Health's (TFAH) 19th annual report on the nation’s obesity, State of Obesity 2022: Better Policies for a Healthier America found that four in ten American adults have obesity, and obesity rates continue to climb nationwide.
Figure 2. Global Anti-Obesity Drug Market Value (US$ Million), By Region, 2023
Anti-Obesity Drug Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients